Navigation Links
China Biologic Products Reports Strong Third Quarter 2008 Results
Date:11/12/2008

TAI'AN, China, Nov. 12 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic," the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today reported financial results for the third quarter ended September 30, 2008.

Third Quarter 2008 Highlights

-- Revenues increased 54.4% year-over-year to $13.8 million

-- Gross profit increased 45.1% to $9.7 million over the third quarter

2007

-- Gross margin was 70%, compared 74.5% for the same period last year

-- Operating income totaled $7.0 million, up 97.3% from the previous year

-- Net income totaled $4.5 million, or $0.21 per diluted share

"We are pleased to report strong revenue and net income results in the third quarter, primarily due to price increases for our plasma-based products and lower operating expenses," said Mr. Chao Ming Zhao, CEO of China Biologic Products, "During the quarter, the SFDA renewed our GMP certification for our newly constructed plasma-based products facility that has 700 tons of annual production capacity. We also received approval to commence clinical trials of Human Coagulation Factor VIII. More recently, we were pleased to announce two proposed acquisitions that will transform China Biologic into the largest non- state-owned plasma-based biopharmaceutical company in China."

During the quarter, the Company achieved the following milestones:

-- Received renewal of its certification of compliance with Good

Manufacturing Practices ("GMP") set by the PRC's State Food and Drug

Administration (the "SFDA")

-- Received approval to commence clinical trial of Human Coagulation

Factor VIII product ("FVIII"), a coagulation treatment for hemophilia

and mass hemorrhaging

Third Quarter 2008 Results

Revenues for the third quarter of 2008 were $13.8 million, up
'/>"/>

SOURCE China Biologic Products, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
5. China Technology Announces New Chief Financial Officer
6. China Medical Technologies Reports First Quarter Financial Results
7. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference
8. China Technology Announces Entry to the Solar Energy Sector
9. China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products
10. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
11. China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... -- Decision Resources Group finds that the vascular access device market in ... India and China (BRIC) ... the size of the United States market ... faster growth as a result of strong economic expansion, improving access ... from Decision Resources Group,s coverage of the BRIC vascular access device ...
(Date:8/20/2014)... SAN JOSE, Calif. , Aug. 20, 2014 ... UCSD highlights the transformative collaboration between the school,s ... (IoT).  As part of the Intel® Software Academic ... between computer sciences and the human body.  ... The study exhibits the work of ...
(Date:8/19/2014)... One of the major limitations in ... vascular supply. Nutrient and gas transport throughout synthetic ... for successful regeneration and integration into the patient’s ... vascularization and promote angiogenesis in a variety of ... and architecture, and enhancing scaffolds with stem cells. ...
(Date:8/19/2014)... August 19, 2014 Cellgen ... raise $200,000 to fund a corporate lab for ... , This development is a critical component in ... care to the implementation of personalized medicine – ... practicing medicine. , Indiegogo contributions will support Cellgen’s ...
Breaking Biology Technology:BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 2BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 3Intel and University of San Diego Bioengineering Department Release Case Study on Health Sciences Research 2Vascularization in Tissue Engineering Highlighted at 12th New Jersey Symposium on Biomaterials Science 2Cellgen Diagnostics Launches Indiegogo Crowdfunding Campaign for DNA Medical Testing Device 2Cellgen Diagnostics Launches Indiegogo Crowdfunding Campaign for DNA Medical Testing Device 3
... March 11 earthquake and rolling blackouts that are severely ... internship program NanoJapan is scrambling to run its annual ... travel to Japan for lab internships, NanoJapan is offering ... students to Rice University laboratories for three months. ...
... 25, 2011 WaferGen Biosystems, Inc. (OTCBB:WGBS), a ... announced it has entered into definitive agreements with ... Partners, LLC, Deerfield Management and Merlin Nexus, and ... a $30.4 million private placement financing of equity ...
... Texas, May 25, 2011 /PRNewswire/ -- ... company, today announced that the United States Patent and Trademark ... patent entitled "Saposin D and Fam3C are Biomarkers for Alzheimer,s ... Fam3c as well as combinations that include these biomarkers. ...
Cached Biology Technology:Reverse NanoJapan: Rice to host 25-30 Japanese students 2WaferGen Announces $30 Million Financing 2WaferGen Announces $30 Million Financing 3WaferGen Announces $30 Million Financing 4Vermillion Announces Notice of Allowance for Alzheimer Patent 2Vermillion Announces Notice of Allowance for Alzheimer Patent 3
(Date:8/19/2014)... in supermarkets to encourage healthier spending habits? A new ... very question by tracking the purchasing records in a ... rate the nutritional value of foods for sale. , ... Just, PhD, and Brian Wansink PhD, author of Slim ... 150 Hannaford Supermarkets in the Northeastern United States between ...
(Date:8/19/2014)... at retail seafood counters in 10 different states ... consumers to unexpectedly high levels of mercury, a ... a fish of the same species, but from ... offense, according to new research by University of ... seafood is essential to allow consumers to choose ...
(Date:8/19/2014)... seas during warm phases and became extinct during cold ... a link between marine crocodilian diversity and the evolution ... 140 million years. , The research, led by ... and formerly from the University of Bristol, UK is ... crocodiles are ,cold-blooded, animals that mainly live in fresh ...
Breaking Biology News(10 mins):Seafood substitutions can expose consumers to unexpectedly high mercury 2Seafood substitutions can expose consumers to unexpectedly high mercury 3Evolution of marine crocodilians constrained by ocean temperatures 2
... methods and better testing systems are needed to advance ... to a series of review articles in Human ... Ann Liebert, Inc ( www.liebertpub.com ). The articles and ... www.liebertpub.com/hum Prostate cancer is one of the ...
... Oxford, 12 July 2010 - The British Mycological Society, ... technical and medical information, today announced the final programme ... Fungi. This congress takes place every 4 years at ... the Edinburgh International Conference Centre, a comprehensive programme encompasses ...
... with your chip shot? Constant drills with your wedge may ... a new study shows why. Previous studies have shown ... better than practice focused on a single task. Cognitive neuroscientists ... paradox in a new study in Nature Neuroscience . ...
Cached Biology News:Innovation and current status of prostate cancer gene therapy featured in Human Gene Therapy 2The biology of fungi -- 1.5 million species -- 1 congress 2Why (smart) practice makes perfect 2
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Request Info...
QML offers standard and customized paraffin embedded tissue blocks....
Request Info...
Biology Products: